# Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults

> **NCT00782548** · PHASE4 · COMPLETED · sponsor: **Actavis Inc.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** KADIAN (morphine sulfate sustained-release) capsules
- **DRUG:** Avinza (morphine sulfate sustained-release) capsules

## Key facts

- **NCT ID:** NCT00782548
- **Lead sponsor:** Actavis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2004-06
- **Final completion:** 2004-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00782548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00782548, "Comparative Study to Evaluate KADIAN and Avinza in Healthy Adults". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00782548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*